Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
Top Sells
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$780M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$335M |
| 3 |
Dimensional National Municipal Bond ETF
DFNM
|
+$315M |
| 4 |
STL
Sterling Bancorp
STL
|
+$283M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$265M |
Sector Composition
| 1 | Financials | 16.89% |
| 2 | Technology | 16.18% |
| 3 | Industrials | 12.16% |
| 4 | Healthcare | 10.84% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
First Business Financial Services
FBIZ
$431M
| $15.6M | ﹤0.01% |
475,540
+10,374
| +2% | +$340K |
|
|
MRTX
2102
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.6M | ﹤0.01% |
189,529
+104,215
| +122% | +$8.57M |
|
2103
Clarus
CLAR
$147M
| $15.5M | ﹤0.01% |
682,042
+35,333
| +5% | +$805K |
|
2104
Acadia Pharmaceuticals
ACAD
$3.98B
| $15.5M | ﹤0.01% |
641,223
-19,029
| -3% | -$461K |
|
2105
Independent Bank Corp
IBCP
$657M
| $15.5M | ﹤0.01% |
705,310
+59,782
| +9% | +$1.32M |
|
2106
Farmers National Banc Corp
FMNB
$554M
| $15.5M | ﹤0.01% |
909,240
+391
| +0% | +$6.67K |
|
2107
Beazer Homes USA
BZH
$781M
| $15.4M | ﹤0.01% |
1,013,201
+5,052
| +0.5% | +$76.9K |
|
2108
Sanofi
SNY
$115B
| $15.4M | ﹤0.01% |
300,009
+1,391
| +0.5% | +$71.4K |
|
|
PETQ
2109
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $15.4M | ﹤0.01% |
631,142
+94,759
| +18% | +$2.31M |
|
2110
Syndax Pharmaceuticals
SNDX
$1.34B
| $15.4M | ﹤0.01% |
884,334
+90,634
| +11% | +$1.58M |
|
2111
Construction Partners
ROAD
$7.02B
| $15.3M | ﹤0.01% |
585,455
+52,860
| +10% | +$1.38M |
|
2112
BCB Bancorp
BCBP
$148M
| $15.3M | ﹤0.01% |
839,823
+27,577
| +3% | +$503K |
|
|
TEN
2113
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $15.3M | ﹤0.01% |
836,106
+46,577
| +6% | +$853K |
|
|
RAD
2114
DELISTED
Rite Aid Corporation
RAD
| $15.3M | ﹤0.01% |
1,750,144
+733,923
| +72% | +$6.42M |
|
2115
Par Pacific Holdings
PARR
$1.67B
| $15.2M | ﹤0.01% |
1,170,057
+87,950
| +8% | +$1.15M |
|
2116
Aspen Aerogels
ASPN
$543M
| $15.2M | ﹤0.01% |
441,247
+21,112
| +5% | +$728K |
|
2117
Fate Therapeutics
FATE
$111M
| $15.1M | ﹤0.01% |
389,116
-25,361
| -6% | -$983K |
|
|
EGRX
2118
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $15.1M | ﹤0.01% |
304,784
+15,055
| +5% | +$745K |
|
2119
Pitney Bowes
PBI
$1.96B
| $15.1M | ﹤0.01% |
2,898,030
+115,108
| +4% | +$599K |
|
2120
CRISPR Therapeutics
CRSP
$5.12B
| $15.1M | ﹤0.01% |
239,987
-19,054
| -7% | -$1.2M |
|
2121
CommScope
COMM
$3.61B
| $15.1M | ﹤0.01% |
1,909,861
+78,555
| +4% | +$619K |
|
2122
DocuSign
DOCU
$16.1B
| $15M | ﹤0.01% |
140,185
-1,809
| -1% | -$194K |
|
|
INN
2123
Summit Hotel Properties
INN
$623M
| $14.9M | ﹤0.01% |
1,495,898
-54,998
| -4% | -$548K |
|
2124
Powell Industries
POWL
$3.47B
| $14.9M | ﹤0.01% |
766,414
-32,508
| -4% | -$631K |
|
2125
OrthoPediatrics
KIDS
$493M
| $14.9M | ﹤0.01% |
275,186
+17,631
| +7% | +$952K |
|